Lysophosphatidyl-choline 16:0 mediates persistent joint pain through Acid-Sensing Ion Channel 3: preclinical and clinical evidences
Florian Jacquot, Spiro Khoury, Bonnie Labrum, Kévin Delanoe, Ludivine Pidoux, Julie Barbier, Lauriane Delay, Agathe Bayle, Youssef Aissouni, David André Barrière, Kim Kultima, Eva Freyhult, A. Katus Hugo, Eva Kosek, Aisha Siddiqah Ahmed, , Emmanuel Deval
The paper identifies LPC16:0 as a mediator of chronic joint pain through ASIC3, supported by preclinical and clinical evidence.
Pain · Jan 27, 2022Peer-reviewedNeuroscience